S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Stock market today: Global markets are mixed as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
TKO Group Knocks Out WrestleMania Event Record
Novo Nordisk Arms Wegovy to Be a Triple Threat
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Stock market today: Global markets are mixed as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
TKO Group Knocks Out WrestleMania Event Record
Novo Nordisk Arms Wegovy to Be a Triple Threat
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Stock market today: Global markets are mixed as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
TKO Group Knocks Out WrestleMania Event Record
Novo Nordisk Arms Wegovy to Be a Triple Threat
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Stock market today: Global markets are mixed as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
TKO Group Knocks Out WrestleMania Event Record
Novo Nordisk Arms Wegovy to Be a Triple Threat
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota

Reata Pharmaceuticals (RETA) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.

Reata Pharmaceuticals Short Interest Data

Current Short Volume
2,390,000 shares
Previous Short Volume
2,600,000 shares
Change Vs. Previous Month
-8.08%
Dollar Volume Sold Short
$411.08 million
Short Interest Ratio / Days to Cover
2.4
Last Record Date
September 15, 2023
Outstanding Shares
38,150,000 shares
Float Size
25,330,000 shares
Short Percent of Float
9.44%
Today's Trading Volume
1,988,500 shares
Average Trading Volume
1,091,032 shares
Today's Volume Vs. Average
182%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Reata Pharmaceuticals ?

Sign up to receive the latest short interest report for Reata Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RETA Short Interest Over Time

RETA Days to Cover Over Time

RETA Percentage of Float Shorted Over Time

Reata Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/20232,390,000 shares $411.08 million -8.1%9.4%2.4 $172.00
8/31/20232,600,000 shares $439.40 million -38.1%10.3%2.7 $169.00
8/15/20234,200,000 shares $710.35 million +4.0%16.7%4.2 $169.13
7/31/20234,040,000 shares $668.94 million +5.5%13.8%3.7 $165.58
7/15/20233,830,000 shares $417.97 million -4.5%13.2%5.1 $109.13
6/30/20234,010,000 shares $408.86 million +2.6%13.7%5.2 $101.96
6/15/20233,910,000 shares $366.02 million -10.1%13.4%5.1 $93.61
5/31/20234,350,000 shares $391.72 million -15.0%15.0%5.8 $90.05
5/15/20235,120,000 shares $433.15 million +6.9%17.6%3.5 $84.60
4/30/20234,790,000 shares $473.54 million -7.4%16.7%3.4 $98.86
4/15/20235,170,000 shares $488.82 million +2.6%18.6%3.5 $94.55
3/31/20235,040,000 shares $458.24 million +0.2%18.1%3.5 $90.92
3/15/20235,030,000 shares $434.74 million -39.8%18.1%3.5 $86.43
2/28/20238,360,000 shares $260.58 million -5.3%30.4%6.1 $31.17
2/15/20238,830,000 shares $375.28 million +5.0%32.1%10.2 $42.50
1/31/20238,410,000 shares $364.41 million +3.3%30.4%13.7 $43.33
1/15/20238,140,000 shares $310.79 million +2.0%29.4%13.8 $38.18
12/30/20227,980,000 shares $303.16 million +9.0%28.8%11.3 $37.99
12/15/20227,320,000 shares $254.30 million -8.0%26.1%10.4 $34.74
11/30/20227,960,000 shares $315.06 million +9.2%28.4%10.7 $39.58
11/15/20227,290,000 shares $303.77 million +10.0%26.0%8.1 $41.67
10/31/20226,630,000 shares $213.49 million +24.2%23.8%6.8 $32.20
10/15/20225,340,000 shares $161.32 million +3.9%18.6%5.5 $30.21
9/30/20225,140,000 shares $129.17 million +3.8%17.9%6.6 $25.13
9/15/20224,950,000 shares $142.31 million +18.4%17.3%6.5 $28.75
8/31/20224,180,000 shares $99.94 million -11.3%14.6%5.6 $23.91
8/15/20224,710,000 shares $97.07 million -6.7%16.4%8.2 $20.61
7/31/20225,050,000 shares $154.93 million +0.4%17.5%10.3 $30.68
7/15/20225,030,000 shares $179.22 million +0.2%17.5%11.6 $35.63
6/30/20225,020,000 shares $152.56 million +2.0%17.4%10.7 $30.39
6/15/20224,920,000 shares $153.70 million +5.4%17.7%8.1 $31.24
5/31/20224,670,000 shares $132.07 million -6.6%16.8%7.7 $28.28
5/15/20225,000,000 shares $122.70 million -1.6%18.0%7.6 $24.54
4/30/20225,080,000 shares $128.93 million +10.7%17.1%7.6 $25.38
4/15/20224,590,000 shares $156.56 million +21.1%15.4%6.8 $34.11
3/31/20223,790,000 shares $124.16 million +11.8%12.8%5.4 $32.76
3/15/20223,390,000 shares $108.11 million +40.1%11.4%5.3 $31.89
2/28/20222,420,000 shares $79.23 million -3.2%8.2%2.4 $32.74
2/15/20222,500,000 shares $66.88 million -15.3%8.4%2.7 $26.75
1/31/20222,950,000 shares $82.95 million -23.6%10.0%3.2 $28.12
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

RETA Short Interest - Frequently Asked Questions

What is Reata Pharmaceuticals' current short interest?

Short interest is the volume of Reata Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 2,390,000 shares of RETA short. 9.44% of Reata Pharmaceuticals' shares are currently sold short. Learn More on Reata Pharmaceuticals' current short interest.

What is a good short interest ratio for Reata Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RETA shares currently have a short interest ratio of 2.0. Learn More on Reata Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Reata Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.44% of Reata Pharmaceuticals' floating shares are currently sold short.

Is Reata Pharmaceuticals' short interest increasing or decreasing?

Reata Pharmaceuticals saw a drop in short interest during the month of September. As of September 15th, there was short interest totaling 2,390,000 shares, a drop of 8.1% from the previous total of 2,600,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Reata Pharmaceuticals' float size?

Reata Pharmaceuticals currently has issued a total of 38,150,000 shares. Some of Reata Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Reata Pharmaceuticals currently has a public float of 25,330,000 shares.

How does Reata Pharmaceuticals' short interest compare to its competitors?

9.44% of Reata Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Reata Pharmaceuticals: Intra-Cellular Therapies, Inc. (3.58%), Apellis Pharmaceuticals, Inc. (8.66%), Ionis Pharmaceuticals, Inc. (7.11%), Jazz Pharmaceuticals plc (5.41%), Viking Therapeutics, Inc. (8.64%), Blueprint Medicines Co. (7.14%), Elanco Animal Health Incorporated (2.53%), Cerevel Therapeutics Holdings, Inc. (11.06%), Cytokinetics, Incorporated (13.33%), BridgeBio Pharma, Inc. (10.29%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($8.05 billion), T-Mobile US, Inc. ($3.94 billion), Charter Communications, Inc. ($3.77 billion), Occidental Petroleum Co. ($3.27 billion), Tractor Supply ($2.29 billion), Celsius Holdings, Inc. ($2.20 billion), Rivian Automotive, Inc. ($2.10 billion), Moderna, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($1.90 billion), and T. Rowe Price Group, Inc. ($1.90 billion). View all of the most shorted stocks.

What does it mean to sell short Reata Pharmaceuticals stock?

Short selling RETA is an investing strategy that aims to generate trading profit from Reata Pharmaceuticals as its price is falling. RETA shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Reata Pharmaceuticals?

A short squeeze for Reata Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RETA, which in turn drives the price of the stock up even further.

How often is Reata Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RETA, twice per month. The most recent reporting period available is September, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:RETA) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners